Evidence map›Paper›PMID 22865643›Full record

ArticleGenetic epidemiology2012

A sample selection strategy for next-generation sequencing.

Chul Joo Kang, Paul Marjoram

Abstract read
In one paragraph

Article in Genetic epidemiology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Chul Joo KangDepartment of Preventive Medicine, Keck School of Medicine, USC, Los Angeles, California, USA.
Paul Marjoram

Funding

Statistical Methods for Relating Sequence Data to PhenotypeR01MH084678 · NIMH · UNIVERSITY OF SOUTHERN CALIFORNIA · PI MARJORAM, PAUL · 2008 to 2010
$1.6M
Design and Analysis of 2 Stage GWAS Study Using Next Generation Sequence TechnoloU01HG005927 · NHGRI · UNIVERSITY OF SOUTHERN CALIFORNIA · PI MARJORAM, PAUL · 2010 to 2010
$225k
NHGRI NIH HHS HG005927NHGRI NIH HHS U01 HG005927NIMH NIH HHS MH084678NIMH NIH HHS R01 MH084678
6 · The paper itself

Abstract

Next-generation sequencing technology provides us with vast amounts of sequence data. It is efficient and cheaper than previous sequencing technologies, but deep resequencing of entire samples is still expensive. Therefore, sensible strategies for choosing subsets of samples to sequence are required. Here we describe an algorithm for selection of a sub-sample of an existing sample if one has either of two possible goals in mind: maximizing the number of new polymorphic sites that are detected, or improving the efficiency with which the remaining unsequenced individuals can have their types imputed at newly discovered polymorphisms. We then describe a variation on our algorithm that is more focused on detecting rarer variants. We demonstrate the performance of our algorithm using simulated data and data from the 1000 Genomes Project.

Indexed as

AlgorithmsGenome, HumanPolymorphism, Single NucleotideComputer SimulationDiploidyGenetic VariationGenome-Wide Association StudyHaplotypesHigh-Throughput Nucleotide SequencingHuman Genome ProjectHumansModels, GeneticSequence Analysis, DNA

Identifiers

PMID22865643
PMCPMC4272568

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.